Invesco India Pharma and Healthcare Fund - Regular (G)

The Scheme seeks to generate long-term capital appreciation by primarily investing in equity and equity related securities of the companies in the Pharmaceuticals, Healthcare and allied sectors, both within India and internationally. The Scheme will follow active investment strategy and will invest across market capitalization. Investments will be made in stocks of companies engaged in Pharmaceuticals, Healthcare, Hospital & Diagnostics, Medical Equipment & Accessories, Distribution, research & manufacturing services, Biotechnology, Healthcare research, innovation, analytics & technology, Hygiene, personal healthcare, fitness & wellness, Insurance and allied sectors that, directly or indirectly supports the pharma value chain. The Scheme also aims to identify and invest in emerging healthcare trends. The above are only indicative and Scheme may invest in any other business or service directly or indirectly forming part of the pharma, healthcare and allied sectors forming part of the Benchmark Index. Risk Control Risk is an inherent part of the investment function. Effective risk management is critical to fund management for achieving financial soundness. Investments by the Scheme shall be made as per the investment objectives of the Scheme and provisions of SEBI (MF) Regulations. AMC has incorporated adequate safeguards to manage risk in the portfolio construction process. Risk control would involve managing risk in order to keep it in line with the investment objective of the Scheme. The risk control process involves identifying the risk and taking proper measures for the same. Risk such as Liquidity risk, volatility risk, Interest rate risk and such other risk can be partly mitigated through diversification, staggering of maturities, as well as internal controls. The Scheme may also use various derivatives products in accordance with the scheme objective and within the regulatory restriction for the purpose of trading, hedging and portfolio balancing from time to time, with an attempt to protect the value of the portfolio and enhance Unitholders` interest. While these measures are expected to mitigate the above risks to a large extent, there can be no assurance that this risk would be completely eliminated. Investment in Derivatives The Scheme may invest in various derivative instruments which are permissible under the applicable Regulations and shall also be subject to the investment objective and strategy of the Scheme and the internal limits if any, as laid down from time to time. These include but are not limited to futures (both stock and index) and options (stock and index). For detailed derivative strategies, please refer to SAI. t